Try our Advanced Search for more refined results

'Novel' Disclosure Issue Not Ready For Del. Supreme Court

By Rose Krebs (October 15, 2019, 5:15 PM EDT) -- The Delaware Supreme Court on Monday refused to revive a suit by an investor challenging DAVA Pharmaceuticals Inc.'s $600 million sale to Endo Pharmaceuticals Inc., ruling that the "novel" question of whether corporations should have the same disclosure duties as individual fiduciaries is not "ripe for review."...

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!